Behcet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy

被引：0
|
作者：
Gomez-Puerta, Jose A.
Espinosa, Gerard
Miro, Jose M.
Sued, Omar
Llibre, Josep M.
Cervera, Ricard
Font, Josep
机构：
[1] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Infect Dis Serv, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin, Inst Clin Med & Dermatol, Dept Autoimmune Dis, E-08036 Barcelona, Spain
[3] Hosp Calella, Barcelona, Spain
来源：
ISRAEL MEDICAL ASSOCIATION JOURNAL | 2006年 / 8卷 / 07期
关键词：
Behcet's disease; human immunodeficiency virus; uveitis; oral ulcers; genital ulcers;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：513 / 514
页数：2
相关论文
共 50 条
  • [31] Impact of highly active antiretroviral therapy on clinical evolution of genital warts in HIV-1-infected patients
    Orlando, G
    Fasolo, MM
    Signori, R
    Schiavini, M
    Casella, A
    Cargnel, A
    AIDS, 1999, 13 (02) : 291 - 293
  • [32] T-cell apoptosis in HIV-1-infected individuals receiving highly active antiretroviral therapy
    Böhler, T
    Debatin, KM
    Wintergerst, U
    BLOOD, 2001, 97 (06) : 1898 - 1900
  • [33] Immune reconstitution in HIV-1-infected individuals treated with potent antiretroviral therapy
    Connick, E
    JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2001, 6 (03) : 212 - 218
  • [34] Avascular necrosis (AVN) in HIV-infected patient treated with highly active antiretroviral therapy (HAART)
    Gérard, M
    Hardy, D
    De Wit, S
    Van Laethem, Y
    Clumeck, N
    AIDS, 2000, 14 : S70 - S70
  • [35] A prospective cohort study on the risk of lipodystrophy in HIV-1-infected patients treated with highly active antiretroviral therapy not containing protease inhibitors
    Martinez, E
    Bailey, L
    Milinkovic, A
    Blanco, JL
    Lonca, M
    Laguno, M
    Leon, A
    Mallolas, J
    Phillips, AN
    Gatell, JM
    ANTIVIRAL THERAPY, 2003, 8 (04) : L80 - L80
  • [36] Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy
    Piroth, L
    Grappin, M
    Petit, JM
    Buisson, M
    Duong, M
    Chavanet, P
    Portier, H
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2001, 33 (07) : 559 - 560
  • [37] Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy
    Bernasconi, E
    Uhr, M
    Magenta, L
    Ranno, A
    Telenti, A
    AIDS, 2001, 15 (08) : 1081 - 1082
  • [38] MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy
    Blankson, JN
    Siliciano, RF
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05): : 549 - 551
  • [39] Predictors of virological failure in HIV-1-infected adults on a stable lamivudine highly active antiretroviral therapy regimen
    Borroto-Esoda, K
    Benson, C
    Quinn, JB
    Hinkle, J
    Harris, J
    Moxham, C
    Rousseau, F
    ANTIVIRAL THERAPY, 2002, 7 : S144 - S144
  • [40] Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands
    Nellen, JF
    Wit, FW
    de Wolf, F
    Jurriaans, S
    Lange, JM
    Prins, JM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (04) : 943 - 950
12345